Catovic Suad, Popovic Zoran B, Tasic Nebojsa, Nezic Dusko, Milojevic Predrag, Djukanovic Bosko, Gradinac Sinisa, Angelkov Lazar, Otasevic Petar
General Hospital, Novi Pazar, Serbia.
J Cardiothorac Surg. 2011 Apr 13;6:51. doi: 10.1186/1749-8090-6-51.
Prognostic value of concomitant aprtic regurgitation (AR) in patients operated for severe aortic stenosis (AS) is not clarified. The aim of this study was to prospectively examine the impact of presence and severity of concomitant AR in patients operated for severe AS on long-term functional capacity, left ventricular (LV) function and mortality.
Study group consisted of 110 consecutive patients operated due to severe AS. The patients were divided into AS group (56 patients with AS without AR or with mild AR) and AS+AR group (54 patients with AS and moderate, severe or very severe AR). Follow-up included clinical examination, six minutes walk test (6MWT) and echocardiography 12 and 104 months after AVR.
Patients in AS group had lower LV volume indices throughout the study than patients in AS+AR group. Patients in AS group did not have postoperative decrease in LV volume indices, whereas patients in AS+AR group experienced decrease in LV volume indices at 12 and 104 months. Unlike LV volume indices, LV mass index was significantly lower in both groups after 12 and 104 months as compared to preoperative values. Mean LVEF remained unchanged in both groups throughout the study. NYHA class was improved in both groups at 12 months, but at 104 months remained improved only in patients with AS. On the other hand, distance covered during 6MWT was longer at 104 months as compared to 12 months only in AS+AR group (p = 0,013), but patients in AS group walked longer at 12 months than patients in AS+AR group (p = 0,002). There were 30 deaths during study period, of which 13 (10 due to cardiovascular causes) in AS group and 17 (12 due to cardiovascular causes) in AS+AR group. Kaplan-Meier analysis showed that the survival probability was similar between the groups. Multivariate analysis identified diabetes mellitus (beta 1.78, p = 0.038) and LVEF < 45% (beta 1.92, p = 0.049) as the only independent predictor of long-term mortality.
Our data indicate that the preoperative presence and severity of concomitant AR has no influence on long-term postoperative outcome, LV function and functional capacity in patients undergoing AVR for severe AS.
对于接受严重主动脉瓣狭窄(AS)手术的患者,合并主动脉瓣反流(AR)的预后价值尚不明确。本研究的目的是前瞻性地研究合并AR的存在及严重程度对接受严重AS手术患者的长期功能能力、左心室(LV)功能和死亡率的影响。
研究组由110例因严重AS接受手术的连续患者组成。患者被分为AS组(56例无AR或伴有轻度AR的AS患者)和AS+AR组(54例伴有中度、重度或极重度AR的AS患者)。随访包括临床检查、六分钟步行试验(6MWT)以及主动脉瓣置换术(AVR)后12个月和104个月的超声心动图检查。
在整个研究过程中,AS组患者的左心室容积指数低于AS+AR组患者。AS组患者术后左心室容积指数没有下降,而AS+AR组患者在12个月和104个月时左心室容积指数下降。与左心室容积指数不同,两组在12个月和104个月后的左心室质量指数均显著低于术前值。整个研究过程中,两组的平均左心室射血分数(LVEF)均保持不变。两组在12个月时纽约心脏协会(NYHA)心功能分级均有所改善,但在104个月时仅AS组患者仍保持改善。另一方面,仅在AS+AR组中,104个月时6MWT期间行走的距离比12个月时更长(p = 0.013),但AS组患者在12个月时比AS+AR组患者行走得更远(p = 0.002)。研究期间有30例死亡,其中AS组13例(10例因心血管原因),AS+AR组17例(12例因心血管原因)。Kaplan-Meier分析显示两组的生存概率相似。多因素分析确定糖尿病(β值1.78,p = 0.038)和LVEF < 45%(β值1.92,p = 0.049)是长期死亡率的唯一独立预测因素。
我们的数据表明,术前合并AR的存在及严重程度对接受严重AS的AVR手术患者的术后长期结局、LV功能和功能能力没有影响。